Abiopharma

🔍 Rakita Melanie (Executive)

Company: L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 3,596 shares of Common Stock, Par Value $1.00 (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,788.49 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,416 shares of Common Stock, Par Value $1.00 at $313.37 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,372.49 | transaction_form_type: 4
• Sold 2,180 shares of Common Stock, Par Value $1.00 at $310.45 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,192.49 | transaction_form_type: 4
• Sold 3,596 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | Exercise: 2026-05-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: Includes 61.29 shares acquired through the Issuer's retirement plan based on information provided by the plan's administrators as of 4/3/2026.
• F2: Each restricted stock unit represented a contingent right to receive one share of the Issuer's common stock and vested on 5/1/2026.